Aidan: Created page with "== Management == === Risk Factor Modification === * Dyslipidemia If CV risk >20%, high-intensity statin regardless of baseline lipids If CV risk 7.5 to 20%, can use mo..."

2021-02-23T16:38:11Z

Created page with "== Management == === Risk Factor Modification === * Dyslipidemia ** If CV risk >20%, high-intensity statin regardless of baseline lipids ** If CV risk 7.5 to 20%, can use mo..."

New page

== Management ==

=== Risk Factor Modification ===

* Dyslipidemia
** If CV risk >20%, high-intensity statin regardless of baseline lipids
** If CV risk 7.5 to 20%, can use moderate-intensity statin
* Hypertension
** Following lifestyle modification, preference should be given to ACE inhibitors and ARBs
* Diabetes mellitus
** Good glycemic control
** Likely benefits from SGLT-2 inhibitors
* Diet & exercise
* Cardiac rehab
* Annual influenza vaccination

=== Coronary Artery Disease ===

* Antiplatelet therapy: long-term ASA is recommended
* Anticoagulation: can consider low-dose rivaroxaban 2.5 mg PO bid in addition to ASA if at high risk for CV disease and low bleeding risk
* Lipid-lowering: see above
* Beta-blockers
** Used primarily as anti-anginal medication
*** Alternatives include calcium channel blockers and long-acting nitrates
*** Can use combination therapy if still symptomatic
** Definitely indicated after ACS or heart failure, but unclear benefit in stable IHD
* RAS inhibitors: indicated with acute MI, heart failure, LCEF <40%, diabetes, and proteinuric chronic kidney disease

[[Category:Cardiology]]

Stable ischemic heart disease - Revision history

Aidan: Created page with "== Management == === Risk Factor Modification === * Dyslipidemia ** If CV risk >20%, high-intensity statin regardless of baseline lipids ** If CV risk 7.5 to 20%, can use mo..."

Aidan: Created page with "== Management == === Risk Factor Modification === * Dyslipidemia If CV risk >20%, high-intensity statin regardless of baseline lipids If CV risk 7.5 to 20%, can use mo..."